Healthcare - Biotechnology - NASDAQ - US
$ 0.295
-1.57 %
$ 9.9 M
Market Cap
-0.28
P/E
Price Target
Average
577.97%
Revenue Forecast
Estimate
-0.00%
EBIT
Estimate
18.92%
Net Income
Estimate
27.19%
WALL STREET ESTIMATES
Wall Street Analysts Price Targets
Vincerx Pharma, Inc.
Wall Street analysts predict an average 1-year price target for VINC of $2 , with forecasts ranging from a low of $2 to a high of $2 .
VINC Lowest Price Target
Wall Street Target
2 USD
577.97%
VINC Average Price Target
Wall Street Target
2 USD
577.97%
VINC Highest Price Target
Wall Street Target
2 USD
577.97%
REVENUE FORECAST
Revenue Forecast Chart VINC
EBIT FORECAST
EBIT Forecast Chart VINC
NET INCOME FORECAST
Net Income Chart VINC